Event December 14, 2023
Advancing the Development of Therapeutics Through Rare Disease Patient Community Engagement
This public meeting will expand upon the FDA’s current efforts by highlighting and building upon...
Read MoreEvent January 23–24, 2024
FDA Convening
Advancing Drug Development for the Prevention of Spontaneous Preterm Birth
Duke-Margolis under a cooperative agreement with the U.S. Food and Drug Administration (FDA), is...
Read MoreEvent March 19–20, 2024
FDA Convening
Enhancing Adoption of Innovative Clinical Trial Approaches
A two-day hybrid Public Workshop on March 19-20, 2024 to identify these barriers and potential...
Read More